In the Journals

Coffee, chocolate linked to improved liver health in HIV/HCV patients

December 26, 2013
Patients coinfected with HIV and hepatitis C may experience a reduction in abnormal liver enzymes and an overall improvement in liver function with…
In the Journals

Variables may predict HCV patients likely to respond to peginterferon/ribavirin

December 20, 2013
Using baseline data in combination with rapid virologic response status, researchers reported they may be able to predict which hepatitis C genotype…
In the Journals

Telaprevir reduced HCV treatment duration in HIV-coinfected patients

December 19, 2013
Adding telaprevir to pegylated interferon and ribavirin for the treatment of acute genotype 1 hepatitis C infection in HIV-positive men reduced the…
Industry News

Sofosbuvir/ledipasvir single tablet for HCV yielded strong SVR12 results

December 18, 2013
A once-daily, fixed-dose combination of sofosbuvir and ledipasvir given to patients with chronic hepatitis C genotype 1 virus resulted in sustained…

Idenix, Janssen begin phase 2 study of all-oral DAA therapy for HCV

December 17, 2013
Idenix Pharmaceuticals and Janssen Pharmaceuticals have begun enrollment in a phase 2 clinical trial to evaluate an all-oral, direct-acting antiviral…
Industry News

Regimen offers SVR12 in 96% of treatment-experienced HCV patients

December 13, 2013
An all-oral, interferon-free combination of three direct-acting antiviral agents combined with ribavirin achieved sustained virologic response in 96%…
In the Journals

HCV treatment linked to improved outcomes in diabetic patients

December 12, 2013
Pegylated interferon plus ribavirin therapy resulted in improved renal and cardiovascular results for diabetic patients with hepatitis C infection as…
In the Journals

Barriers to HCV care include lack of physical symptoms, treatment side effects

December 11, 2013
Barriers to hepatitis C care for patients enrolled in opioid substitution treatment included the perception of being physically well and concerns…
Business News

Cocrystal, Biozone to merge

December 9, 2013
Biozone Pharmaceuticals and Cocrystal Discovery have signed a letter of intent to merge, according to a press release. Among Cocrystal’s lead…
FDA approvals

FDA approves once-daily oral sofosbuvir combination as hepatitis C treatment

December 6, 2013
The FDA today approved once-daily oral nucleotide analog sofosbuvir as part of an antiviral regimen for the treatment of hepatitis C patients with…